Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19.

Published on Feb 9, 2021in Mbio6.784
· DOI :10.1128/MBIO.03192-20
Ryan M. Pace10
Estimated H-index: 10
(UIdaho: University of Idaho),
Janet E. Williams21
Estimated H-index: 21
(UIdaho: University of Idaho)
+ 18 AuthorsMichelle K. McGuire34
Estimated H-index: 34
(UIdaho: University of Idaho)
Sources
Abstract
ABSTRACT Whether mother-to-infant SARS-CoV-2 transmission can occur during breastfeeding and, if so, whether the benefits of breastfeeding outweigh this risk during maternal COVID-19 illness remain important questions. Using RT-qPCR, we did not detect SARS-CoV-2 RNA in any milk sample (n = 37) collected from 18 women following COVID-19 diagnosis. Although we detected evidence of viral RNA on 8 out of 70 breast skin swabs, only one was considered a conclusive positive result. In contrast, 76% of the milk samples collected from women with COVID-19 contained SARS-CoV-2-specific IgA, and 80% had SARS-CoV-2-specific IgG. In addition, 62% of the milk samples were able to neutralize SARS-CoV-2 infectivity in vitro, whereas milk samples collected prior to the COVID-19 pandemic were unable to do so. Taken together, our data do not support mother-to-infant transmission of SARS-CoV-2 via milk. Importantly, milk produced by infected mothers is a beneficial source of anti-SARS-CoV-2 IgA and IgG and neutralizes SARS-CoV-2 activity. These results support recommendations to continue breastfeeding during mild-to-moderate maternal COVID-19 illness. IMPORTANCE Results from prior studies assaying human milk for the presence of SARS-CoV-2, the causative virus of COVID-19, have suggested milk may act as a potential vehicle for mother-to-child transmission. Most previous studies are limited because they followed only a few participants, were cross-sectional, and/or failed to report how milk was collected and/or analyzed. As such, considerable uncertainty remains regarding whether human milk is capable of transmitting SARS-CoV-2 from mother to child. Here, we report that repeated milk samples collected from 18 women following COVID-19 diagnosis did not contain SARS-CoV-2 RNA; however, risk of transmission via breast skin should be further evaluated. Importantly, we found that milk produced by infected mothers is a source of anti-SARS-CoV-2 IgA and IgG and neutralizes SARS-CoV-2 activity. These results support recommendations to continue breastfeeding during mild-to-moderate maternal COVID-19 illness as milk likely provides specific immunologic benefits to infants.
📖 Papers frequently viewed together
24 Citations
2 Citations
65 Citations
References39
Newest
#1Cuifang Fan (WHU: Wuhan University)H-Index: 6
#2Di Lei (WHU: Wuhan University)H-Index: 5
Last. Suqing Wang (RMIT: RMIT University)H-Index: 2
view all 12 authors...
We presented two cases of COVID-19 associated SARS-CoV-2 infection during third trimester of pregnancy. Both mothers and newborns had excellent outcomes. We failed to identify SARS-CoV-2 in all the products of conception and the newborns. This report provided evidence of low risk of intrauterine infection by vertical transmission of SARS-CoV-2.
189 CitationsSource
#1Alisa Fox (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 5
#2Jessica Marino (UCM: University of California, Merced)H-Index: 2
Last. Rebecca L.R. Powell (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 6
view all 7 authors...
The SARS-CoV-2 immune response in human milk has not yet been examined, though protecting infants and young children from COVID-19 is critical for limiting community transmission, and preventing serious illness and death. Here, milk samples from 8 COVID-19-recovered and 7 COVID-19-suspected donors were tested for antibody (Ab) binding to the SARS-CoV-2 Spike protein. All samples exhibited significant specific IgA reactivity to the full Spike, while 80% exhibited significant IgA and secretory (s)...
54 CitationsSource
#1Christina D. Chambers (UCSD: University of California, San Diego)H-Index: 60
#2Paul Krogstad (UCLA: University of California, Los Angeles)H-Index: 36
Last. Grace M. Aldrovandi (UCLA: University of California, Los Angeles)H-Index: 56
view all 7 authors...
This Research Letter reports on the results of SARS-CoV-2 present in the breast milk of 18 infected US women.
86 CitationsSource
#1Guangtong Deng (CSU: Central South University)H-Index: 8
#2Furong Zeng (CSU: Central South University)H-Index: 8
Last. Mingzhu Yin (CSU: Central South University)H-Index: 21
view all 6 authors...
Liver injury is not very severe in pregnant COVID-19 patients. Pregnant COVID-19 patients with liver injury had higher inflammation than those without liver injury. All newborns delivered by pregnant COVID-19 patients with liver injury were negative for SARS-CoV-2.
6 CitationsSource
#1Kimberly A. Lackey (UIdaho: University of Idaho)H-Index: 13
#2Ryan M. Pace (UIdaho: University of Idaho)H-Index: 10
Last. Michelle K. McGuire (UIdaho: University of Idaho)H-Index: 34
view all 11 authors...
50 CitationsSource
#1Phuong Nguyen-Contant (URMC: University of Rochester Medical Center)H-Index: 4
#2A. Karim Embong (URMC: University of Rochester Medical Center)H-Index: 1
Last. Mark Y. Sangster (URMC: University of Rochester Medical Center)H-Index: 34
view all 8 authors...
The high susceptibility of humans to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the cause of coronavirus disease 2019 (COVID-19), reflects the novelty of the virus and limited preexisting B cell immunity. IgG against the SARS-CoV-2 spike (S) protein, which carries the novel receptor binding domain (RBD), is absent or at low levels in unexposed individuals. To better understand the B cell response to SARS-CoV-2 infection, we asked whether virus-reactive memory B cells...
60 CitationsSource
#1F. Javier Ibarrondo (UCLA: University of California, Los Angeles)H-Index: 10
#2Jennifer A. Fulcher (UCLA: University of California, Los Angeles)H-Index: 21
Last. Otto O. Yang (UCLA: University of California, Los Angeles)H-Index: 56
view all 10 authors...
Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...
522 CitationsSource
#1Yunzhu DongH-Index: 1
#2Xiangyang ChiH-Index: 1
Last. Wei ChenH-Index: 1
view all 7 authors...
A maternal woman was positive for SARS-CoV-2 tested in throat swabs but negative tested in other body fluids, and she had IgG and IgA detected in breast milk. Her infant negative for SARS-CoV-2 at birth had elevated IgG in serum but quickly decayed. These findings suggest that breastfeeding might have the potential benefit to the neonates.
58 CitationsSource
#1Jennifer Hicks (NIH: National Institutes of Health)H-Index: 6
#1Jennifer Hicks (NIH: National Institutes of Health)H-Index: 6
Last. Kaitlyn Sadtler (NIH: National Institutes of Health)H-Index: 16
view all 14 authors...
In order to properly understand the spread of SARS-CoV-2 infection and development of humoral immunity, researchers have evaluated the presence of serum antibodies of people worldwide experiencing the pandemic. These studies rely on the use of recombinant proteins from the viral genome in order to identify serum antibodies that recognize SARS-CoV-2 epitopes. Here, we discuss the cross-reactivity potential of SARS-CoV-2 antibodies with the full spike proteins of four other Betacoronaviruses that ...
34 CitationsSource
#1Quanxin Long (LMB: Laboratory of Molecular Biology)H-Index: 17
#1Quan Xin Long (LMB: Laboratory of Molecular Biology)H-Index: 2
Last. Ailong Huang (LMB: Laboratory of Molecular Biology)H-Index: 37
view all 19 authors...
The clinical features and immune responses of asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described. We studied 37 asymptomatic individuals in the Wanzhou District who were diagnosed with RT-PCR-confirmed SARS-CoV-2 infections but without any relevant clinical symptoms in the preceding 14 d and during hospitalization. Asymptomatic individuals were admitted to the government-designated Wanzhou People's Hospital for central...
1,488 CitationsSource
Cited By33
Newest
#1Vivian Valcarce (UF: University of Florida)
#2Stafford Ls (UF: University of Florida)H-Index: 1
Last. Joseph Larkin (UF: University of Florida)H-Index: 28
view all 0 authors...
Background: In 2019, a deadly virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), emerged. In December 2020, two mRNA-based COVID-19 vaccines were approved for use in the United States, which provide immunity to those receiving the vaccine. Maternally derived antibodies are a key element of infants' immunity. Certain vaccines given to pregnant and lactating mothers provide immunity to infants through transmission acros...
Source
Source
#1Christine Bäuerl (CSIC: Spanish National Research Council)H-Index: 12
#2Walter Randazzo (CSIC: Spanish National Research Council)H-Index: 19
Last. Francesca Crovetto (University of Barcelona)H-Index: 21
view all 17 authors...
Objectives null To develop and validate a specific protocol for SARS-CoV-2 detection in breast milk matrix and to determine the impact of maternal SARS-CoV-2 infection on the presence, concentration and persistence of specific SARS-CoV-2 antibodies. null Design and patients null This is a prospective, multicentre longitudinal study (April–December 2020) in 60 mothers with SARS-CoV-2 infection and/or who have recovered from COVID-19. A control group of 13 women before the pandemic were also inclu...
Source
#1Low Jm (NUS: National University of Singapore)
#2Yue Gu (NUS: National University of Singapore)H-Index: 1
Last. Rashi Gupta (NUS: National University of Singapore)H-Index: 1
view all 0 authors...
Lactating women can produce protective antibodies in their milk after vaccination, which has informed antenatal vaccination programs for diseases such as influenza and pertussis. However, whether SARS-CoV-2-specific antibodies are produced in human milk as a result of COVID-19 vaccination is still unclear. In this study, we show that lactating mothers who received the BNT162b2 vaccine secreted SARS-CoV-2-specific IgA and IgG antibodies into milk, with the most significant increase at 3-7 days po...
Source
#1Vignesh Narayanaswamy (UMass: University of Massachusetts Amherst)
#2Brian T. Pentecost (UMass: University of Massachusetts Amherst)H-Index: 15
Last. Heidi Leftwich (UMMS: University of Massachusetts Medical School)H-Index: 3
view all 9 authors...
Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus. Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Four of 15 women provided liquid colostrum, which was used for validating results obtained from spot cards. Archived bilateral co...
Source
#1Esteve-Palau EH-Index: 1
#2Gonzalez-Cuevas AH-Index: 1
Last. Vicens Diaz-BritoH-Index: 1
view all 7 authors...
Source
The COVID-19 pandemic has produced an unprecedented global health crisis. Vulnerable populations, such as breastfeeding mother-infant dyads, are in a particularly delicate situation. Before, during, and after birth mothers and their infants could be exposed to the virus. Due to fear of infection transmission, there has been an increase in separation of COVID-positive mothers and their infants and a decline in breastfeeding, despite research supporting the provision of mother's milk for her infan...
Source
#1Jill K BairdH-Index: 1
#1Baird JkH-Index: 1
Last. Jason R. Baird (Providence Portland Medical Center)H-Index: 19
view all 5 authors...
BackgroundThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has infected over 127 million people worldwide, with almost 2.8 million deaths at the time of writing. Since no l...
2 CitationsSource
#1Lars Bode (University of California, Berkeley)H-Index: 2
#2Kerri Bertrand (University of California, Berkeley)H-Index: 1
Last. Joseph J. CampoH-Index: 18
view all 9 authors...
One potential mechanism for protection from SARS-CoV-2 in infants and young children is through passive immunity via breast milk from a mother previously infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2 specific IgA and IgG and to characterize the specific antigenic regions of SARS-CoV-2 proteins that were reactive with antibodies in breast milk from women with confirmed SARS-CoV-2 infection. null Between March 2020 and Septem...
Source
#1Caroline J. Duncombe (UW: University of Washington)
#2Denise J. McCulloch (UW: University of Washington)H-Index: 10
Last. Helen Y. Chu (UW: University of Washington)H-Index: 31
view all 8 authors...
Abstract null null Background null : While a growing body of literature describes antibody dynamics in serum, little is known about breast milk antibody titers in the months following SARS-CoV-2 infection. null null null Objectives null : We evaluated the dynamics of the humoral immune response to SARS-CoV-2 in two women who were breastfeeding when infected. We assessed paired breast milk and serum samples for six months post-infection for antibodies specific to the SARS-CoV-2 receptor binding d...
Source